Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I

This study has been terminated.
(Due to slow enrolment.)
The Ryan Foundation
University of California, Los Angeles
FDA Office of Orphan Products Development
Information provided by (Responsible Party):
Patricia I. Dickson, M.D., Dickson, Patricia I., M.D. Identifier:
First received: September 19, 2005
Last updated: February 20, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)